US Stock MarketDetailed Quotes

Allogene Therapeutics (ALLO)

Watchlist
  • 2.000
  • -0.140-6.54%
Close May 15 16:00 ET
  • 2.010
  • +0.010+0.50%
Post 19:47 ET
690.31MMarket Cap-2.60P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Allogene Therapeutics (ALLO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
75.60%-12.91M
25.49%-149.25M
24.79%-27.6M
32.70%-29.69M
38.62%-39.03M
5.31%-52.93M
15.75%-200.3M
31.67%-36.7M
20.56%-44.12M
-2.80%-63.59M
Net income from continuing operations
28.67%-42.61M
25.90%-190.89M
35.25%-38.81M
37.55%-41.4M
23.23%-50.94M
8.10%-59.73M
21.29%-257.59M
30.12%-59.94M
-6.43%-66.29M
16.25%-66.36M
Operating gains losses
----
----
----
----
----
----
-84.18%1.69M
--0
-54.57%1.13M
-115.40%-375K
Depreciation and amortization
-7.42%2.87M
-9.38%12.36M
-5.44%3.06M
-3.43%3.1M
-14.76%3.11M
-12.83%3.1M
-3.94%13.64M
-7.02%3.23M
-10.22%3.21M
0.03%3.64M
Deferred tax
----
--0
----
----
----
----
--443K
----
----
----
Other non cash items
-5.40%1.07M
-17.05%4.36M
-6.18%1.05M
-29.09%1.03M
-25.52%1.15M
-0.88%1.13M
-20.22%5.25M
-33.61%1.12M
-68.23%1.45M
1,032.35%1.54M
Change In working capital
321.50%18.37M
56.14%-10.88M
-103.83%-202K
97.60%-145K
87.84%-2.24M
-46.80%-8.29M
-16.39%-24.8M
203.90%5.27M
68.74%-6.03M
-321.79%-18.39M
-Change in prepaid assets
281.70%1.13M
758.13%3.24M
-45.28%986K
396.19%1.01M
199.89%1.87M
-624.42%-623K
-145.30%-492K
172.99%1.8M
-115.57%-341K
-1,930.39%-1.87M
-Change in payables and accrued expense
20.17%-4.44M
-112.52%-3.75M
-83.49%481K
100.30%14K
-77.47%1.31M
4.29%-5.56M
87.68%-1.77M
18,312.50%2.91M
71.83%-4.7M
233.39%5.83M
-Change in other current assets
-80.24%84K
-130.15%-1.29M
-114.83%-102K
-78.56%315K
-384.79%-1.93M
-70.59%425K
394.09%4.28M
166.54%688K
501.37%1.47M
777.00%677K
-Change in other current liabilities
-13.00%-1.89M
-5.29%-6.37M
7.20%-1.56M
4.77%-1.5M
-3.01%-1.64M
-38.97%-1.67M
8.54%-6.05M
-8.24%-1.68M
64.61%-1.57M
-32,000.00%-1.6M
-Change in other working capital
2,804.95%23.48M
86.97%-2.71M
-100.45%-7K
101.35%12K
---1.84M
---868K
-246.10%-20.77M
199.36%1.55M
---891K
----
Cash from discontinued investing activities
Operating cash flow
75.60%-12.91M
25.49%-149.25M
24.79%-27.6M
32.70%-29.69M
38.62%-39.03M
5.31%-52.93M
15.75%-200.3M
31.67%-36.7M
20.56%-44.12M
-2.80%-63.59M
Investing cash flow
Cash flow from continuing investing activities
-579.08%-29.59M
26.25%95.56M
-38.81%33.61M
115.71%11.94M
-41.25%43.84M
-72.10%6.18M
-53.65%75.69M
-18.57%54.93M
-121.76%-75.99M
334.81%74.61M
Net PPE purchase and sale
90.91%-9K
44.38%-386K
--0
43.36%-243K
---44K
-1,137.50%-99K
54.22%-694K
-41.99%-257K
-3,475.00%-429K
--0
Net investment purchase and sale
-571.38%-29.58M
25.61%95.95M
-39.10%33.61M
116.12%12.18M
-41.19%43.88M
-71.66%6.28M
-53.65%76.38M
-18.41%55.19M
-120.59%-75.56M
327.63%74.61M
Cash from discontinued investing activities
Investing cash flow
-579.08%-29.59M
26.25%95.56M
-38.81%33.61M
115.71%11.94M
-41.25%43.84M
-72.10%6.18M
-53.65%75.69M
-18.57%54.93M
-121.76%-75.99M
334.81%74.61M
Financing cash flow
Cash flow from continuing financing activities
50.98%21.12M
-74.15%30.16M
36.84%7.86M
376.58%3.24M
-95.33%5.07M
747.88%13.99M
21.92%116.68M
3,605.16%5.74M
-84.15%679K
21.31%108.6M
Net common stock issuance
106.64%20.67M
-80.05%22.35M
36.84%7.86M
--2.98M
-98.58%1.51M
--10M
22.98%112.05M
--5.74M
--0
--106.3M
Proceeds from stock option exercised by employees
-28.84%454K
-61.88%895K
--0
-62.15%257K
--0
-61.33%638K
-48.77%2.35M
--0
-37.76%679K
-98.82%19K
Net other financing activities
----
202.98%6.91M
--0
--0
--3.56M
--3.35M
--2.28M
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
50.98%21.12M
-74.15%30.16M
36.84%7.86M
376.58%3.24M
-95.33%5.07M
747.88%13.99M
21.92%116.68M
3,605.16%5.74M
-84.15%679K
21.31%108.6M
Net cash flow
Beginning cash position
-27.52%61.98M
-8.49%85.51M
-21.82%48.11M
-65.39%62.62M
-14.00%52.75M
-8.49%85.51M
29.44%93.45M
-22.64%61.53M
9.64%180.96M
-48.99%61.33M
Current changes in cash
34.75%-21.38M
-196.46%-23.53M
-42.15%13.87M
87.84%-14.52M
-91.74%9.88M
-2.01%-32.76M
-137.35%-7.94M
72.40%23.98M
-39.66%-119.43M
166.87%119.63M
End cash Position
-23.03%40.6M
-27.52%61.98M
-27.52%61.98M
-21.82%48.11M
-65.39%62.62M
-14.00%52.75M
-8.49%85.51M
-8.49%85.51M
-22.64%61.53M
9.64%180.96M
Free cash flow
75.63%-12.92M
25.55%-149.63M
25.32%-27.6M
32.81%-29.93M
38.55%-39.07M
5.15%-53.03M
15.99%-200.99M
31.42%-36.96M
19.80%-44.54M
-2.32%-63.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 75.60%-12.91M25.49%-149.25M24.79%-27.6M32.70%-29.69M38.62%-39.03M5.31%-52.93M15.75%-200.3M31.67%-36.7M20.56%-44.12M-2.80%-63.59M
Net income from continuing operations 28.67%-42.61M25.90%-190.89M35.25%-38.81M37.55%-41.4M23.23%-50.94M8.10%-59.73M21.29%-257.59M30.12%-59.94M-6.43%-66.29M16.25%-66.36M
Operating gains losses -------------------------84.18%1.69M--0-54.57%1.13M-115.40%-375K
Depreciation and amortization -7.42%2.87M-9.38%12.36M-5.44%3.06M-3.43%3.1M-14.76%3.11M-12.83%3.1M-3.94%13.64M-7.02%3.23M-10.22%3.21M0.03%3.64M
Deferred tax ------0------------------443K------------
Other non cash items -5.40%1.07M-17.05%4.36M-6.18%1.05M-29.09%1.03M-25.52%1.15M-0.88%1.13M-20.22%5.25M-33.61%1.12M-68.23%1.45M1,032.35%1.54M
Change In working capital 321.50%18.37M56.14%-10.88M-103.83%-202K97.60%-145K87.84%-2.24M-46.80%-8.29M-16.39%-24.8M203.90%5.27M68.74%-6.03M-321.79%-18.39M
-Change in prepaid assets 281.70%1.13M758.13%3.24M-45.28%986K396.19%1.01M199.89%1.87M-624.42%-623K-145.30%-492K172.99%1.8M-115.57%-341K-1,930.39%-1.87M
-Change in payables and accrued expense 20.17%-4.44M-112.52%-3.75M-83.49%481K100.30%14K-77.47%1.31M4.29%-5.56M87.68%-1.77M18,312.50%2.91M71.83%-4.7M233.39%5.83M
-Change in other current assets -80.24%84K-130.15%-1.29M-114.83%-102K-78.56%315K-384.79%-1.93M-70.59%425K394.09%4.28M166.54%688K501.37%1.47M777.00%677K
-Change in other current liabilities -13.00%-1.89M-5.29%-6.37M7.20%-1.56M4.77%-1.5M-3.01%-1.64M-38.97%-1.67M8.54%-6.05M-8.24%-1.68M64.61%-1.57M-32,000.00%-1.6M
-Change in other working capital 2,804.95%23.48M86.97%-2.71M-100.45%-7K101.35%12K---1.84M---868K-246.10%-20.77M199.36%1.55M---891K----
Cash from discontinued investing activities
Operating cash flow 75.60%-12.91M25.49%-149.25M24.79%-27.6M32.70%-29.69M38.62%-39.03M5.31%-52.93M15.75%-200.3M31.67%-36.7M20.56%-44.12M-2.80%-63.59M
Investing cash flow
Cash flow from continuing investing activities -579.08%-29.59M26.25%95.56M-38.81%33.61M115.71%11.94M-41.25%43.84M-72.10%6.18M-53.65%75.69M-18.57%54.93M-121.76%-75.99M334.81%74.61M
Net PPE purchase and sale 90.91%-9K44.38%-386K--043.36%-243K---44K-1,137.50%-99K54.22%-694K-41.99%-257K-3,475.00%-429K--0
Net investment purchase and sale -571.38%-29.58M25.61%95.95M-39.10%33.61M116.12%12.18M-41.19%43.88M-71.66%6.28M-53.65%76.38M-18.41%55.19M-120.59%-75.56M327.63%74.61M
Cash from discontinued investing activities
Investing cash flow -579.08%-29.59M26.25%95.56M-38.81%33.61M115.71%11.94M-41.25%43.84M-72.10%6.18M-53.65%75.69M-18.57%54.93M-121.76%-75.99M334.81%74.61M
Financing cash flow
Cash flow from continuing financing activities 50.98%21.12M-74.15%30.16M36.84%7.86M376.58%3.24M-95.33%5.07M747.88%13.99M21.92%116.68M3,605.16%5.74M-84.15%679K21.31%108.6M
Net common stock issuance 106.64%20.67M-80.05%22.35M36.84%7.86M--2.98M-98.58%1.51M--10M22.98%112.05M--5.74M--0--106.3M
Proceeds from stock option exercised by employees -28.84%454K-61.88%895K--0-62.15%257K--0-61.33%638K-48.77%2.35M--0-37.76%679K-98.82%19K
Net other financing activities ----202.98%6.91M--0--0--3.56M--3.35M--2.28M--0--0----
Cash from discontinued financing activities
Financing cash flow 50.98%21.12M-74.15%30.16M36.84%7.86M376.58%3.24M-95.33%5.07M747.88%13.99M21.92%116.68M3,605.16%5.74M-84.15%679K21.31%108.6M
Net cash flow
Beginning cash position -27.52%61.98M-8.49%85.51M-21.82%48.11M-65.39%62.62M-14.00%52.75M-8.49%85.51M29.44%93.45M-22.64%61.53M9.64%180.96M-48.99%61.33M
Current changes in cash 34.75%-21.38M-196.46%-23.53M-42.15%13.87M87.84%-14.52M-91.74%9.88M-2.01%-32.76M-137.35%-7.94M72.40%23.98M-39.66%-119.43M166.87%119.63M
End cash Position -23.03%40.6M-27.52%61.98M-27.52%61.98M-21.82%48.11M-65.39%62.62M-14.00%52.75M-8.49%85.51M-8.49%85.51M-22.64%61.53M9.64%180.96M
Free cash flow 75.63%-12.92M25.55%-149.63M25.32%-27.6M32.81%-29.93M38.55%-39.07M5.15%-53.03M15.99%-200.99M31.42%-36.96M19.80%-44.54M-2.32%-63.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -